Trademark: 79194037
Status Date
Monday, February 14, 2022
Filing Date
Friday, July 1, 2016
Published for Opposition
Tuesday, March 12, 2019
Abandoned Date
Monday, February 14, 2022
41 Education services, namely, workshops, webinars, seminars, expert's panel discussions in the field of pharmaceutical data, whether medical, legal, regulatory and/or economic; providing training in the field of understanding and collecting pharmaceutical data, whether medical, legal, regulatory and/or economic; organization and conducting of educational colloquiums, conferences or congresses in the field of understanding and collecting pharmaceutical data, whether medical, legal, regulatory and/or economic
9 Software being recorded programs for use in database management, management and classification of pharmaceutical information and data; software and applications for mobile devices for use in database management, management and classification of pharmaceutical information and data; data communication software for providing scientific and/or economic and/or legal information and data on pharmaceutical proprietary products; computer software for use in data collection, data management and data analysis of pharmaceutical, medical, health-economy and healthcare information ; computer software for use in data collection in the fields clinical trials analysis, market access and Health Technology Assessment (HTA) decisions, Price and Reimbursement (PandR) decisions; computer software for web-based access to data, data collection, data analysis, data integration and preparation of reports in connection with pharmaceutical, medical and health information; downloadable computer software in the form of mobile applications for web-based access to data, data collection, data analysis, data integration and preparation of reports in connection with pharmaceutical, medical and health information
16 Printing products being printed matter, namely, leaflets, posters and brochures providing pharmaceutical data, whether scientific, legal, regulatory and/or economic to the pharmaceutical industry; printed instructional or teaching material except apparatus in the field of delivering pharmaceutical data, whether scientific, legal, regulatory and/or economic to medical practitioners and members of the pharmaceutical industry; newspapers
35 Business management and business consultation in the pharmaceutical, medical, and healthcare fields; business consultation in the field of clinical research and clinical trials, namely, assist pharmaceutical companies with clinical trials approval issues for medicinal products and medical devices; business consultation in the field of market access and submission management, namely, assist pharmaceutical companies on Health Technology Assessment (HTA) and Pricing and Reimbursement (PandR) procedures for medicinal products and medical devices; consultation in the field of data processing and database management services for collection of scientific, economic and regulatory data in the field of medicinal products and medical devices; web-based portal providing business information on medicinal products and medical devices, namely, marketing activities and launching strategies; computerized data management in the pharmaceutical, medical, and healthcare fields; computerized file management in the pharmaceutical, medical, and healthcare fields
44 Providing medical, pharmaceutical, health management, and disease management information relating to pharmaceutical products to others
42 Software design; research and development of new products for others; technical project studies in the field of new technologies in the field of pharmaceutical data; software maintenance; software installation; software rental; updating of software; scientific and technological analyses, namely, scientific and technological consultancy in relation to the development, validation, and regulatory approval of pharmaceutical drugs, biologics, and medical devices; scientific and technological analyses, namely, scientific and technological consultancy on Health Technology Assessment (HTA), clinical development, Pricing and Reimbursement (PandR) strategies, scientific, legal, regulatory and economic information on pharmaceutical drugs, biologics, and medical devices; design of computer software featuring decision-making tools for the pharmaceutical industry on pharmaceutical drugs, biologics, and medical devices; design of computer systems in the pharmaceutical, medical, and healthcare fields; on-line interactive database featuring scientific research information, on pharmaceutical drugs, biologics, and medical devices in the pharmaceutical, medical, and healthcare fields; technical data analysis services, namely, data mining in the field of pharmaceutical data, whether scientific, legal, regulatory and/or economic; advice relating to information technology intended for the pharmaceutical and health industries
Mar 5, 2023
Final Decision Transaction Processed By Ib
Feb 14, 2023
Final Disposition Notice Sent To Ib
Feb 14, 2023
Final Disposition Notice Created, To Be Sent To Ib
Feb 14, 2022
Abandonment Notice E-Mailed - Inter Partes Decision
Feb 14, 2022
Abandonment - After Inter Partes Decision
Feb 14, 2022
Opposition Terminated No. 999999
Feb 14, 2022
Opposition Sustained No. 999999
May 3, 2019
Refusal Processed By Ib
Apr 26, 2019
Notification Processed By Ib
Apr 15, 2019
Opposition Instituted No. 999999
Apr 12, 2019
Opposition Notice (Ib Refusal) Sent To Ib
Apr 12, 2019
Opposition Notice (Ib Refusal) Created
Apr 11, 2019
Opposition Papers Received At Ttab
Mar 12, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2019
Published For Opposition
Feb 20, 2019
Notification Of Possible Opposition Sent To Ib
Feb 20, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 20, 2019
Notification Of Notice Of Publication E-Mailed
Feb 5, 2019
Law Office Publication Review Completed
Feb 3, 2019
Assigned To Lie
Jan 22, 2019
Approved For Pub - Principal Register
Jan 21, 2019
Teas/Email Correspondence Entered
Jan 21, 2019
Correspondence Received In Law Office
Jan 21, 2019
Teas Request For Reconsideration Received
Aug 9, 2018
Notification Of Final Refusal Emailed
Aug 9, 2018
Final Refusal E-Mailed
Aug 9, 2018
Final Refusal Written
Jul 13, 2018
Teas/Email Correspondence Entered
Jul 13, 2018
Correspondence Received In Law Office
Jul 13, 2018
Teas Response To Office Action Received
Apr 6, 2018
Notification Of Possible Opposition - Processed By Ib
Mar 21, 2018
Notification Of Possible Opposition Sent To Ib
Mar 21, 2018
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 9, 2018
Refusal Processed By Ib
Jan 13, 2018
Notification Of Non-Final Action E-Mailed
Jan 13, 2018
Non-Final Action E-Mailed
Jan 13, 2018
Non-Final Action Written
Dec 22, 2017
Notice Of Reinstatement Mailed
Dec 20, 2017
Petition To Director Granted
Dec 4, 2017
Assigned To Petition Staff
Aug 31, 2017
Teas Petition To Director Received
Jul 6, 2017
Teas Change Of Correspondence Received
Jul 3, 2017
Abandonment Notice Mailed - Incomplete Response
Jul 3, 2017
Abandonment - Incomplete Response
May 15, 2017
Notice Of Unresponsive Amendment - Mailed
May 15, 2017
Report Unresponsive Amendment - Completed
Apr 25, 2017
Teas/Email Correspondence Entered
Apr 25, 2017
Correspondence Received In Law Office
Apr 25, 2017
Teas Response To Office Action Received
Nov 18, 2016
Refusal Processed By Ib
Oct 28, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Oct 28, 2016
Refusal Processed By Mpu
Oct 28, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Oct 27, 2016
Non-Final Action Written
Oct 25, 2016
Application Filing Receipt Mailed
Oct 21, 2016
Assigned To Examiner
Oct 21, 2016
New Application Office Supplied Data Entered
Oct 20, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
